21/09/2026
🆕 𝟒.𝟏𝟕/𝟓 - 𝐣𝐨𝐢𝐧𝐭-𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐨𝐯𝐞𝐫𝐚𝐥𝐥 𝐬𝐜𝐨𝐫𝐞 𝐚𝐦𝐨𝐧𝐠 𝟏𝟔 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞𝐝 𝐏𝐨𝐥𝐢𝐬𝐡 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬🚀
👉 We are proud of the result. But what matters even more is 𝐰𝐡𝐚𝐭 𝐭𝐡𝐞 𝐣𝐮𝐝𝐠𝐞𝐬 𝐬𝐚𝐰 𝐛𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐬𝐜𝐨𝐫𝐞.
👉 During the Polish MedTech , VISUAL TECH-LAB was particularly recognized for 𝐩𝐫𝐨𝐛𝐥𝐞𝐦 𝐝𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲. The judging summary described the solution as addressing a “𝐠𝐞𝐧𝐮𝐢𝐧𝐞 𝐮𝐧𝐦𝐞𝐭 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐞𝐞𝐝”, with the potential to 𝐢𝐦𝐩𝐫𝐨𝐯𝐞 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐦𝐚𝐤𝐢𝐧𝐠 and operate within a 𝐥𝐚𝐫𝐠𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲.
👉 For us, this is an important external signal. is being developed to add a 𝐪𝐮𝐚𝐧𝐭𝐢𝐭𝐚𝐭𝐢𝐯𝐞 𝐭𝐢𝐬𝐬𝐮𝐞-𝐝𝐞𝐧𝐬𝐢𝐭𝐲 𝐥𝐚𝐲𝐞𝐫 𝐭𝐨 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐂𝐁𝐂𝐓 𝐢𝐦𝐚𝐠𝐢𝐧𝐠, providing measurable data that can support clinicians at the treatment-planning stage.
When building a medtech company, the key question is not only whether the technology is interesting.
It is whether 𝐭𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐩𝐫𝐨𝐛𝐥𝐞𝐦 𝐢𝐬 𝐫𝐞𝐚𝐥, 𝐭𝐡𝐞 𝐯𝐚𝐥𝐮𝐞 𝐢𝐬 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐚𝐛𝐥𝐞 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐞𝐬 𝐚 𝐫𝐞𝐚𝐬𝐨𝐧 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐭𝐨 𝐞𝐱𝐢𝐬𝐭.
The feedback from Singapore gives us another positive indication that we are working on a problem worth solving. 𝟒.𝟏𝟕/𝟓 𝐢𝐬 𝐚 𝐠𝐫𝐞𝐚𝐭 𝐬𝐜𝐨𝐫𝐞 🙌
𝐑𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐮𝐧𝐦𝐞𝐭 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐧𝐞𝐞𝐝 𝐚𝐧𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐞𝐯𝐞𝐧 𝐦𝐨𝐫𝐞.
Thank you to the judges, organizers and everyone we met in Singapore for the conversations, questions and valuable feedback.
𝐍𝐨𝐰 𝐭𝐡𝐞 𝐟𝐨𝐜𝐮𝐬 𝐫𝐞𝐦𝐚𝐢𝐧𝐬 𝐨𝐧 𝐯𝐚𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧, 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐛𝐫𝐢𝐧𝐠𝐢𝐧𝐠 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭.
Polska Agencja Rozwoju Przedsiębiorczości Netrix.Ventures Puławski Park Naukowo-TechnologicznyWAB - Wschodni Akcelerator Biznesu College of Dental Medicine MUNK Stomatologia & Estetica
